Purpose The survival for patients with lymphoma has improved over the past decades with the introduction of novel agents. Quality of life of these survivors is now being studied with focus on minimising the late effects of chemotherapy and improving psychosocial support. This study aims to determine the prevalence of anxiety and depression of lymphoma survivors and to investigate the possible association between these disorders and quality of life. Methods Patients with previous diagnosis of lymphoma who remained in remission were recruited from a major hospital in Malaysia. Quality of life of these patients was measured using European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C30). Anxiety and depression symptoms were assessed using Hospital Anxiety and Depression scale (HADS). Results A total of 156 patients participated in this study. Eighteen percent (18 %) of patients had symptoms of anxiety, and 10 % had symptoms of depression. Patients who had higher depression scores were older, of lower education level and had more than one comorbidity illness. Patients with anxiety were associated with lower overall quality of life (QOL) score, lower emotional and cognitive functioning and complained more of fatigue and insomnia (p < 0.05). Patients who had depression were associated with lower physical functioning and complained more of insomnia (p < 0.05).
Introduction
Lymphoid neoplasms are one of the most common haematological cancers. In the USA, 84 % of haematological cancers are lymphoid neoplasms [1] . Non-Hodgkin lymphoma (NHL) accounted for approximately 80 % of all lymphoid neoplasms, and Hodgkin lymphoma (HL) accounted for 8 % [2] . NHL is the eighth most common cancer in the USA, and in Malaysia, lymphoma is the sixth most common cancer accounting for about 4.3 % of all cancers [3, 4] . Survival had improved significantly for both NHL and HL in the past decades in many countries including Asian regions [4] [5] [6] . The much improved survival rates and curability for lymphoma in recent years are the result of introduction of monoclonal antibody therapy in combination of chemotherapy drugs and newer radiotherapy technology [7] [8] [9] . In Malaysia, a recent study showed the 3-year overall survival rate of patients with DLBCL was 80 % [10] . With improved survival, patients are now reporting more treatment-related side effects such as cardiac dysfunction, secondary malignancies and gonadal dysfunction. There have been some evidences to show that these may in turn compromise their quality of life (QOL) [11, 12] .
Majority of the studies on QOL in lymphoma survivors were limited to the western populations [13, 14] . A systematic review by Arden-Close et al. showed that the lymphoma survivors had a worse physical HRQOL than the normal population [13] . Age, level of education and gender were found to be some of the factors which may be associated with QOL. In addition to the sociodemographic factors, other factors which include psychological disorder such as depression and anxiety had been shown to affect QOL of lymphoma survivors [15] .
Depression and anxiety symptoms are not uncommon in patients who had been diagnosed of cancers. Many studies had reported a relatively high prevalence of anxiety and depression amongst cancer patients. Haematological cancers are one of the cancers which reported highest distress upon diagnosis [16] [17] [18] . The prevalence rate of anxiety and depression in lymphoma patients were reported to be 14-24 and 4-19 %, respectively, higher than what was reported in normal population [15, 19] . Quality of life had also been demonstrated to be negatively impacted by the presence of anxiety and depression [20, 21] .
To our knowledge, there were very few studies on QOL of haematological cancers patients done in the Southeast Asian region, which has different cultural and socioeconomical backgrounds from the developed countries. Previous QOL studies done in Malaysia focused on patients post haemotopoeitic stem cell transplant (HSCT) and haematological malignancies with active disease [22, 23] . There had not been any reports which study lymphoma survivors.
In view of this, this study aims to evaluate the QOL of lymphoma survivors in a multiethnic and developing country such as Malaysia and to determine the clinical and psychosocial factors which may affect their QOL. We hope the result of this study will enable the treating physicians in identifying the relevant psychosocial factors for early intervention and thus improving QOL of these patients.
Methods Patients
The study involved a cross-sectional survey of lymphoma patients attending the haematology outpatient clinic in University Malaya Medical Centre, Kuala Lumpur from December 2013 to August 2014. The study was approved with the local institution ethics committee. All the lymphoma patients were screened, and patients who fulfilled selection criteria were identified by the haematologists and medical officers. The inclusion criteria were (1) confirmed diagnosis of lymphoma, (2) age 18 years and above, (3) had completed treatment for at least 6 months from the date of recruitment and (4) demonstrated to be complete remission as defined by the international working group criteria [24] . Patients were excluded if (1) they have history of other previous malignancy, (2) they are pregnant or up to 6 weeks post-partum at the time of survey and (3) they are severely ill or had cognitive impairment which limit their ability to complete the questionnaire. All patients provided written informed consent.
The sample size was adequate based on the calculated population of lymphoma patients in the hospital, and the assumption that the prevalence of anxiety or depression is 25 % amongst lymphoma patients and a d value of 0.075.
Study measures
Consented participants were interviewed by two trained research assistants. Patients were asked to complete two validated self-reported questionnaires, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and Hospital Anxiety and Depression Scale (HADS).
EORTC QLQ-C30, a cancer-specific questionnaire, was used in this study to measure QOL [25, 26] . It consists of 30 questions that encompass multi-item scales such as Global Health Status/QOL scale, five functional scales, three symptoms scale and six single items. The functional scales consist of physical functioning (PF), role functioning (RF), emotional functioning (EF), cognitive functioning (CF) and social functioning (SF). Symptom scales or items include fatigue (FA), nausea and vomiting (NV), pain (PA), dyspnoea (DY), insomnia (SL), appetite loss (AP), constipation (CO), diarrhoea (DI) and financial difficulties (FI). Each item was scored in one of four categories: (1) 'not at all', (2) 'a little', (3) 'quite a bit' and (4) 'very much' except Global Health status/QOL, which ranges from 1, 'very poor', to 7 'excellent'. A linear transformation to a '0-100' scale of the EORTC QLQ-C30 questionnaire was carried out according to the EORTC Scoring Manual. High scores on the global and functional scales indicate good QOL. Low scores on symptoms scales represent less intense symptom experience.
Psychopathological comorbidity was assessed by HADS, a well-established screening instrument for depression and anxiety in cancer [27] . It consists of 14 items (7 on depression and 7 on anxiety). The response on each item is being scored 0-3. The score for each subscale (anxiety and depression) ranges from 0 to 21. A cutoff score of 8 and greater per subscale has been recommended as having the best sensitivity and specificity for identifying anxiety and depression [27] . The HADS has been validated for use in patients with cancers including haematological cancers [28, 29] . It is also recommended as the most appropriate tool for identifying clinical significant depression and anxiety amongst patients after cancer treatment [30] .
Both questionnaires were validated and were available in three translated versions, English, Malay and Mandarin, and these were given to patients according to their preferences.
Other demographic data includes age, gender, partner status, ethnicity, education level, presence of other medical illnesses, diagnosis and duration from last treatment received were also collected both from medical folders and from patients themselves.
Statistical analysis
Descriptive analysis were used to analyse the sociodemographic characteristics (age, education level, ethnicity, marital statuscategorized as having a partner or not) and clinical characteristics (presence of comorbidities, diagnosis and time since last treatment received and anxiety and depression scores). Differences between mean rank scores of each QOL item/symptoms within the various demographics and clinical categories were analysed using Mann-Whitney U test and Kruskal-Wallis H test where appropriate. Correlations between the QOL subsets were tested using Spearman's correlation.
A stepwise multiple regression was conducted to determine the best linear individual domain of quality of life with selected independent variables such as age, gender, ethnicity, level of education, marital status, comorbidity, diagnosis, time since completed treatment, anxiety and depression score [31] . Missing values and outliers were excluded from the analysis. Assumptions of linearity, normally distributed errors, uncorrelated errors and multicollinearity were checked. A p value of ≤0.05 was considered as statistically significant. All statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 21.0.
Results
A total of 168 lymphoma survivors were approached for the study and 156 agreed to participate (93 % response rate). There were 63 males and 93 females. The patients' clinical and sociodemographic characteristics are shown in Table 1 . The most common concomitant medical illnesses were dyslipidaemia (45.8 %) and hypertension (26.2 %) followed by diabetes mellitus (20.8 %) and ischaemic heart disease (4.8 %).
There was no difference in the patients who had HADA score of ≥8 in terms of their sociodemographic and clinical characteristics. However, patients who were older, had more than one comorbidity illnesses and lower education level appeared to be significantly associated with higher HADD score (≥8) (p value of <0.05). Table 2 showed the mean scores of all the QOL domains for all patients. Tables 3 and 4 showed the difference of all domains of QOL with the different clinical characteristics of patients by univariate analysis. The result showed that presence of anxiety symptoms affects most of the QOL functioning domains except for social functioning whereas presence of depression symptoms appeared to only affect physical, role and emotion functioning. Patients who had higher anxiety scores also complained of more symptoms. It also appeared that Indian patients had generally lower scores in most QOL functioning domains when compared to other ethnic groups but only role functioning and emotional functioning are significantly lower with univariate analysis. The Indian patients also have higher symptom scores, but only nausea and vomiting and appetite loss are significant after univariate analysis.
After multivariate linear regression analysis, presence of anxiety symptoms was associated with worse global health Patients with depression symptoms had significant lower physical functioning score. Patients with anxiety and depression symptoms were associated with more symptoms of insomnia. Patients who had anxiety also reported more fatigue and pain. Presence of comorbidity was associated with poorer physical functioning. After multivariate analysis, Indian patients were found to be significantly associated with poorer emotional functioning (Table 5) .
Discussion
The mean score of GHS in this study was 76.17, and this is comparable with other studies of lymphoma survivors using the same measurements [32, 33] . However, similar studies in Malaysia and Denmark reported a lower GHS score of lymphoma patients and the likely reason for the discrepancy is the different patients' cohort where they included patients who had active disease [23, 34] . A review article by Arden-Close et al. found that lymphoma survivors experience worse physical QOL compared to the general population and age, education level, employment status and comorbidities are some of the determining factors [13] . Similarly, Jensen et al. demonstrated that survivors of aggressive NHL had worse QOL if they are younger, single, lack of private insurance as well as presence of comorbidities [35] . In our study, we were not able to compare our results with the normal Malaysian population due to the lack of data on healthy population. We also did not find any sociodemographic factors which affect the overall GHS. Interestingly, presence of anxiety and depression appeared to have a more significant effect on QOL of our lymphoma survivors. In this study, we found 18 and 10 % of our lymphoma survivors exhibit clinically significant anxiety and depression. It is well reported that the prevalence rate of anxiety and depression is higher amongst patients with cancers compared to the general population [14, 19] . In a recent study, 19 % of cancer patients had clinical significant anxiety and 12.9 % had depression [17] . There are few international surveys which specifically study the prevalence of anxiety and depression in patients with haematological cancers. A recent study by Clinton-McHarg et al. reported that 27 % of patients with haematological cancers had anxiety and 17 % had depression [16] . In Malaysia, Priscilla et al. reported 31 % of patients with haematological cancers had anxiety disorder and 25 % had major depressive disorder [36] . The lower prevalence rate compared to those reported was due to the different patient's cohorts where those studies included patients of other haematological cancers, e.g. acute leukaemia and those in active disease. Hence, it is not surprising that the prevalence rate is higher due to the ongoing psychosocial and physical stress associated with the underlying active disease and therapy [36] . However, our result was similar to the study by Oerlemans et al. who observed that anxiety and depression occurred in about 10-15 % of lymphoma survivors which is reportedly higher than the normal population [15] . Similarly, our lymphoma survivors reported much higher prevalence of anxiety and depression compared to normal healthy population in Malaysia where the reported prevalence rate of anxiety and depression was only 1.7 and 1.8 % respectively [37] . However, the measurement tool used in this survey may have been different from the one we used, and hence, this should be interpreted cautiously. In our study, we found that patients, who are older, who had lower education level and had more than one comorbidities reported more depression symptoms, but we found no significant association with anxiety and patients' sociodemographic characteristics.
Anxiety and depression had been showed to affect the overall QOL of patients with cancers including haematological cancers [21, [38] [39] [40] . Self-reported anxiety amongst our patients appeared to adversely affect their QOL including emotional and cognitive functioning. They also tend to complain more of insomnia, pain and fatigue.
Depression is one of the strongest predictors for reduced QOL in cancer patients [38, 41] . In a study by Priscilla et al., patients with depression had poorer social functioning and complained more of nausea and vomiting, insomnia and financial difficulties [36] . In this study, patients with depression had poorer physical functioning and complained more of insomnia. It is uncertain if the poorer physical functioning leads to more depression symptoms or the other way round. We found no significant association of financial difficulties with presence of depression symptoms as compared to previously reported by Priscilla et al. [35] . This is again likely that most patients in this study had already completed their treatment for more than 2 years. However, it is important to note that patients who had just completed treatment tend to complain more of financial difficulties, although this was no longer significant after multivariate analysis. It would be important to explore further this in a larger sample especially there had been study which reported that Asian patients tend to worry about cost of treatment compared to the Caucasians [42] . Interestingly, ethnicity appeared to affect emotional functioning of patients. In this study, Indian patients reported significantly lower emotional functioning score compared to the other two ethnic groups. Indians patients also tend to have more symptoms of nausea and vomiting and appetite loss, although this was not statistically significant after multivariate analysis. In a study which looked at QOL of post-haematopoietic stem cell transplantation Malaysian patients, the author also found that Indian patients tend to had more symptoms compared to the other two ethnic groups [22] . Symptoms such as cancer pain in different ethnic groups had been extensively reviewed and found that indeed there is difference in cancer pain between ethnicities [43] . There had been also studies elsewhere which demonstrated ethnicity affect QOL of patients with differences in the prevalence rate of anxiety and depression as well as symptom burdens [42, 44, 45] . The reasons hypothesised by the authors for these differences were possible lack of language skills, different cultural background and socioeconomic status amongst the ethnic minority when compared to the Caucasian patients. However, there is no literature thus far which looked specifically at the QOL of different ethnic groups within Asia. The significant lower emotional functioning score in the Indian patients would be an interesting starting point for future study. Fatigue is a common problem amongst various types of cancers including lymphoma and could persist for years amongst cancer survivors, with interference on daily life [46] . More than half of our patients reported fatigue symptom. A similar finding was noted amongst Danish lymphoma patients [34] . American Society of Clinical Oncology (ASCO) recommended screening for fatigue at diagnosis of cancer as part of distress screening that evaluates emotional health and QOL. Yearly screening as well as anytime when patient has fatigue symptoms during treatment and recovery was recommended. Although this practice has not been emphasized in our local clinical settings, the relatively high scores of fatigue compared to the other symptoms should highlight the needs for local healthcare givers to be more sensitive to the presence of this symptom which may be manageable nonpharmacologically and pharmacologically.
Hodgkin lymphoma survivors are also found to have a lower emotional functioning although this was not statistically significant after multivariate analysis. However, this may need further exploration as patients with HL were usually diagnosed at a younger age compared to NHL patients, and being diagnosed at a younger age had probably a greater impact on their QOL. It has been demonstrated elsewhere that adult survivors of childhood cancers had poorer emotional health, with lower likelihood of current employment, or being married and also had lower income [47] . This study has several limitations. Firstly, the lack of QOL scores for normal population in Malaysia did not allow us to make any comparison. Secondly, the sample size is relatively small and diverse to make any strong conclusion. However, despite these limitations, the study provides a comprehensive assessment of QOL of lymphoma survivors in Southeast Asian countries where cultural and socioeconomic background is different from the western countries.
In conclusion, this study demonstrated that there are a significant number of patients who had been viewed as survivors by many, have anxiety and depression which adversely affect their QOL. This is a timely report especially now there is an increasing awareness amongst the physicians treating cancer patients to screen for distress and the implementation of routine screening in clinical practice is strongly suggested as a measure for improving cancer care [48] . The result of this study demonstrated that screening of distress and assessment of health-related QOL should also be extended to cancer survivors. 
